PCI Biotech: Fourth quarter and preliminary full year 2014 results


Lysaker, 24 February 2015.

Please find attached the presentation and report for Q4 2014 and preliminary full year 2014 results.

The presentation will be held 24 February at 08:00 at Felix Konferansesenter.

Kind regards,
Per Walday
CEO
Email: pw@pcibiotech.no
Mobil: +47 917 93 429

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.


Attachments

PCI Biotech Q4 2014 Presentation PCI Biotech Q4 2014 Report
GlobeNewswire